180 Wealth Advisors, LLC Eli Lilly & CO Transaction History

180 Wealth Advisors, LLC

$629 Million
Q3 2024

A detailed history of 180 Wealth Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, 180 Wealth Advisors, LLC holds 2,693 shares of LLY stock, worth $2.21 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

2,693

Previous 2,829 4.81%

Holding current value

$2.21 Million

Previous $2.56 Million 6.87%

% of portfolio

0.38%

Previous 0.43%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$772.14 - $960.02 $105,011 - $130,562	-136 Reduced 4.81%	2,693 $2.39 Million
Q2 2024 Jul 16, 2024	SELL	$724.87 - $909.04 $1.52 Million - $1.91 Million	-2,098 Reduced 42.58%	2,829 $2.56 Million
Q1 2024 Apr 15, 2024	BUY	$592.2 - $792.28 $1.29 Million - $1.73 Million	2,186 Added 79.75%	4,927 $3.83 Million
Q4 2023 Jan 24, 2024	SELL	$525.19 - $619.13 $14,180 - $16,716	-27 Reduced 0.98%	2,741 $1.6 Million
Q3 2023 Oct 31, 2023	SELL	$434.7 - $599.3 $9,563 - $13,184	-22 Reduced 0.79%	2,768 $1.49 Million
Q2 2023 Jul 11, 2023	SELL	$350.74 - $468.98 $17,887 - $23,917	-51 Reduced 1.8%	2,790 $1.31 Million
Q1 2023 Apr 07, 2023	BUY	$310.63 - $364.82 $49,390 - $58,006	159 Added 5.93%	2,841 $975,000
Q4 2022 Feb 02, 2023	BUY	$321.55 - $374.67 $33,762 - $39,340	105 Added 4.07%	2,682 $981,000
Q3 2022 Oct 12, 2022	BUY	$296.48 - $337.87 $246,078 - $280,432	830 Added 47.51%	2,577 $833,000
Q2 2022 Jul 11, 2022	SELL	$278.73 - $327.27 $44,318 - $52,035	-159 Reduced 8.34%	1,747 $567,000
Q1 2022 Apr 22, 2022	SELL	$234.69 - $291.66 $37,081 - $46,082	-158 Reduced 7.66%	1,906 $566,000
Q4 2021 Jan 26, 2022	SELL	$224.85 - $279.04 $90,389 - $112,174	-402 Reduced 16.3%	2,064 $502,000
Q3 2021 Oct 28, 2021	SELL	$221.6 - $272.71 $4,210 - $5,181	-19 Reduced 0.76%	2,466 $587,000
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $16,971 - $21,952	-94 Reduced 3.64%	2,485 $670,000
Q1 2021 May 25, 2021	SELL	$164.32 - $212.72 $42,558 - $55,094	-259 Reduced 9.13%	2,579 $515,000
Q4 2020 Jan 27, 2021	SELL	$130.46 - $172.63 $66,404 - $87,868	-509 Reduced 15.21%	2,838 $563,000
Q3 2020 Oct 23, 2020	BUY	$146.22 - $169.13 $46,351 - $53,614	317 Added 10.46%	3,347 $481,000
Q2 2020 Jul 21, 2020	BUY	$136.42 - $164.18 $21,008 - $25,283	154 Added 5.35%	3,030 $503,000
Q1 2020 Apr 09, 2020	BUY	$119.05 - $147.35 $342,387 - $423,778	2,876 New	2,876 $409,000

Others Institutions Holding LLY

# of Institutions

3,912

Shares Held

765M

Call Options Held

6.35M

Put Options Held

7.96M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $778B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 180 Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 180 Wealth Advisors, LLC with notifications on news.

Account

180 Wealth Advisors, LLC Eli Lilly & CO Transaction History